Literature DB >> 16673508

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673508

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  11 in total

1.  Global eradication of polio: the case for "finishing the job".

Authors:  Chandrakant Lahariya
Journal:  Bull World Health Organ       Date:  2007-06       Impact factor: 9.408

2.  Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.

Authors:  Judith E Mueller; Maël Bessaud; Q Sue Huang; Laura C Martinez; Patricia A Barril; Viviane Morel; Jean Balanant; Judy Bocacao; Joanne Hewitt; Brad D Gessner; Francis Delpeyroux; Silvia V Nates
Journal:  Appl Environ Microbiol       Date:  2009-01-05       Impact factor: 4.792

3.  The risks, costs, and benefits of possible future global policies for managing polioviruses.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

4.  Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

Authors:  Carla Magda Allan S Domingues; Sirlene de Fátima Pereira; Ana Carolina Cunha Marreiros; Nair Menezes; Brendan Flannery
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

5.  Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.

Authors:  Lei Ma; Wei Cai; Mingbo Sun; Yina Cun; Jian Zhou; Jing Liu; Wenzhu Hu; Xinwen Zhang; Shaohui Song; Shude Jiang; Guoyang Liao
Journal:  Hum Vaccin Immunother       Date:  2016-08-15       Impact factor: 3.452

6.  A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers.

Authors:  Beatriz Quiambao; Olivier Van Der Meeren; Devayani Kolhe; Salvacion Gatchalian
Journal:  Hum Vaccin Immunother       Date:  2012-02-14       Impact factor: 3.452

Review 7.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 8.  From emergence to eradication: the epidemiology of poliomyelitis deconstructed.

Authors:  Neal Nathanson; Olen M Kew
Journal:  Am J Epidemiol       Date:  2010-10-26       Impact factor: 4.897

Review 9.  Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.

Authors:  Thomas R Hird; Nicholas C Grassly
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

Review 10.  Matrix and backstage: cellular substrates for viral vaccines.

Authors:  Ingo Jordan; Volker Sandig
Journal:  Viruses       Date:  2014-04-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.